HBsAg positive means hepatitis B infection is present, but it does not automatically mean you need medicine immediately. You need testing to decide whether it is acute, chronic, or inactive infection.
Medicines used if treatment is needed
For chronic hepatitis B, usual first-line antiviral medicines are:
- Tenofovir disoproxil fumarate (TDF)
- Tenofovir alafenamide (TAF)
- Entecavir
These suppress the virus and lower the risk of cirrhosis and liver cancer. WHO recommends tenofovir or entecavir as preferred options when antiviral therapy is indicated.
WHO HBV guidance
Do not start, stop, or choose these medicines without a liver specialist or physician. Choice depends on HBV DNA level, ALT/liver enzymes, FibroScan or other fibrosis assessment, kidney function, pregnancy status, HIV status, and previous treatment. Entecavir should not be used alone until HIV is excluded.
If this is a new acute infection
Most healthy adults with acute hepatitis B recover without antiviral medication. Treatment is usually rest, fluids, avoiding alcohol and liver-toxic medicines, plus monitoring. Severe acute hepatitis may need hospital care and antiviral therapy.
Tests to request soon
See a gastroenterologist/hepatologist or physician and ask for:
- HBV DNA viral load
- HBeAg and anti-HBe
- Liver function tests: ALT, AST, bilirubin, albumin, INR
- Anti-HBc IgM and total anti-HBc
- Ultrasound and/or FibroScan
- HIV, hepatitis C, and hepatitis D tests
- Kidney function before tenofovir
Important now
- Avoid alcohol completely.
- Do not take unprescribed herbal or Ayurvedic products, as some can injure the liver.
- Household members and sexual partners should be tested and vaccinated if not immune.
- Use condoms until your partner’s immunity is confirmed.
- If pregnant, tell your obstetrician urgently. Tenofovir may be used to reduce transmission to the baby in appropriate situations.
Go to urgent care immediately for yellow eyes/skin with confusion, severe vomiting, bleeding, increasing abdominal swelling, extreme sleepiness, or severe abdominal pain.
Recent research is exploring drugs aimed at a “functional cure,” but standard treatment remains long-term viral suppression with medicines such as tenofovir or entecavir. A 2025 systematic review discusses these emerging therapies (
PubMed PMID 40528088).